A randomized efficacy trial of citicoline in patients with acute ischemic stroke

Stroke

Volumn 30, Issue 12, 1999, Pages 2592-2597

  Clark, Wayne M ^a   Williams, Benjamin J ^b   Selzer, Kenneth A ^c   Zweifler, Richard M ^f   Sabounjian, LuAnn A ^d,e   Gammans, Richard E ^d,e  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b FORSYTH MEDICAL CENTER   (United States)

^c SCRIPPS MEMORIAL HOSPITAL   (United States)

^d UNIVERSITY OF SOUTH ALABAMA   (United States)

^e Interneuron Pharmaceuticals Inc   (United States)

^f NONE

Author keywords

Citicoline; Stroke; Treatment

Indexed keywords

CITICOLINE; FREE RADICAL;

ADULT; AGED; ARTICLE; CELL MEMBRANE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032709479     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.12.2592     Document Type: Article

References (31)

1. Kennedy EP. The metabolism and function of complex liquids. Harvey Lect. 1963;57:143-171.
2. Bazan NG Jr. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim Biophys Acta. 1970;218:1-10.
3. Yatsu FM, Moss SA. Brain lipid changes following hypoxia. Stroke. 1971;2:587-593.
4. Majeswska MD, Strosznajder J, Lazarewicz J. Effect of ischemic anoxia and barbiturate anesthesia on free radical oxidation of mitochondrial phospholipids. Brain Res. 1976;110:547-557.
5. Trovarelli G, DeMedio GE, Dorman RV, Piccinin GL, Horrocks LA, Porcellati G. Effect of cytidine diphosphate choline (CDP-choline) on ischemia-induced alterations of brain lipid in the gerbil. Neurochem Res. 1981;6:821-833.
6. Dorman RV, Dabrowiecki Z, DeMedio GE, Trovarelli G, Porcellati G, Horroks LA. Control of lipid metabolism in ischemic brain CDPamines. In: Horroks LA, Ansell GB, Porcellati G, eds. Phospholipids in the Nervous System. Vol I: Metabolism. New York: Raven Press Publishers; 1982:123-135.
7. Weiss GB. Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline. Life Sci. 1995;56: 637-660.
8. Kakihana M, Fukuda N, Suno M, Nagaoka A. Effects of CDP-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia. Stroke. 1988;19:217-222.
9. Dorman RV, Dabrowieki Z, Horrocks LA. Effects of CDP choline and CDP ethanolamine on the alterations in rat brain lipid metabolism induced by global ischemia. J Neurochem. 1983;40:276-279.
10. Yamamoto M, Shimizu M, Okamiya H. Pharmacological actions of a new TRH analogue, YM-14673, in rats subjected to cerebral ischemia and anoxia. Eur J Pharmacol. 1990;181:207-214.
11. Boismare F, Le Poncin Lefitte M, Rapin JR, Hemodynamic, functional, and biochemical effects of hypobaric hypoxia in rats treated with cytidine diphosphocholine. Presented at the Comptes rendus des seances de las Societe de Biologie. 1978;172:651.
12. Hamdort G, Cervos-Navarro J. Study of the effects of oral administration of CDP-choline on open-field behaviour under conditions of chronic hypoxia. Arzneimittelforschung/Drug Res. 1990;40:519-522.
13. De Medio GE, Brunett M, Dorman RV, Droz B, Horrocks LA, Porcellati G. Phospholipid metabolism during central and peripheral damage and recovery in nervous tissue. Original article series. Birth Defects. 1983; 19:175-187.
14. Mykita S, Golly F, Dreyfus H, Freysz L, Massarelli R. Effect of CDP-choline on hypocampic neurons in culture. J Neurochem. 1986;47: 223-231.
15. Aronowski J, Strong R, Grotta JC. Citicoline for treatment of experimental focal ischemia: histologic ad behavioral outcome. Neurol Res. 1996;18:570-574.
16. Clark W, Gunion-Rinker L, Lessov N, Hazel K. Citicoline treatment for experimental intracerebral hemorrhage in mice. Stroke. 1998;29: 2136-2140.
17. Goyas JY, Bastard J, Missoum A. Results after 90 days of stroke treatment with CDP-choline, concerning a double blind test. Presented at the International Symposium: Brain suffering and precursors of phospholipids; January 18, 1980; Paris.
18. Boudouresques AB, Michel B. Therapeutic conduct in light of a cerebral vascular accident and the use of CDP-choline. Presented at the International Symposium: Brain suffering and precursors of phospholipids; January 18, 1980; Paris.
19. Corso A, Arena M, Ventimiglia A, Bizzarro G, Campo G, Radalica F. CDP-choline for cerebrovascular disorders: clinical evaluation and evaluation of electrophysiological symptomology. Clin Ter. 1982;102: 379-386.
20. Tazaki Y, Sakai F, Otomo E, Kutsuzawa T, Kameyama M, Omae T, Fujishima T. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. Stroke. 1988;19:211-216.
21. Clark W, Warach S, Pettigrew L, Gammans R, Sabounjian L. A randomized dose response trial of Citicoline in acute ischemic stroke patients. Neurology. 1997;49:671-678.
22. Brott T, Adams H, Olinger C. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864-870.
23. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. MD State Med J. 1965;1461-65.
24. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
25. Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials. 2nd ed. Littleton, Mass: PSG Publishing; 1985.
26. DeGraba T, Hallenbeck J, Pettigrew K, Dutka A, Kelly B. Progression in acute stroke: value of the Initial NIH stroke scale score on patient stratification in future trials. Stroke. 1999;30:1208-1212.
27. The National Institute of Neurological Disorders, and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
28. Hacke W, Kaste M, Fieshchi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnon G, Schneider D, Diez-Tejedor E, Trouillas P (Second European-Australasian Acute Stroke Study Investigators). Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASSII). Lancet. 1998;352:1245-1251.
29. Clark W, Albers G. for the ATLANTIS Stroke Study Investigators. The ATLANTIS rt-PA acute stroke trial: final results. Stroke. 1999;30:234. Abstract.
30. Furlan A, Higashida R, Wechsler L, Schulz G. PROACT II: recombinant prourokinase in acute cerebral thromboembolism. Stroke. 1999;30:234. (Results presented at the 24th International AHA Stroke Conference, February 1999).
31. Adams H, Bendixwn B, Kappelle J, Biller J, Love B, Gordon D, Marsh E. Classification of subtype of acute ischemic stroke. Stroke. 1993;24: 35-41.